Archives

August 2008
Dow Chemical Makes Move in Specialty Chemicals
Dow Chemical will acquire Rohm and Haas for $18.8 billion (Euro 12 billion), taking "a defining step in its transformational strategy," according to Chairman and CEO Andrew Liveris. The Rohm and Haas name and headquarters will be retained for certain specialty chemical businesses, which will incorporate some Dow operations including coatings, biocides and personal care products. Rohm and Haas also provides Dow with greater access to specialty technologies and positions in emerging regions. The combined companies will also benefit from raw material synergies, such as the use of Propylene for acrylic polymer production.

The acquisition comes on the heals of an agreement between Dow and Kuwait Petroleum's Petrochemical Industries Co. (PIC) to transfer five of Dow's basic chemical businesses to a joint venture in which it will retain a 50 percent stake . Dow stated that the Rohm and Haas deal is not contingent on the completion of the deal with PIC.

Analysts believe that Dow is making a positive move for the long term, but that the price of the deal is high. How management handles the integration of the two companies will be a critical factor in the ultimate success of the transaction; cost savings through synergies will not be enough. Dow expects the deal to break even in 2009.
 

 

Chemical Companies in Southeast Asia May Face Turbulent Times
The slowing of the global economy is happening at a time when significant new capacity will be coming onstream in Southeast Asia. Four new Ethylene crackers under construction in Thailand and Singapore will have feedstock and technology advantages, but questions remain as to whether these advantages will be enough to maintain profitability in the face of slowing demand and lower prices. Rising inflation and high food prices in particular, could dramatically impact demand for plastics and other downstream petrochemicals in the region.

 



 
Government Controls Leave China Oil/Petchem Producers Struggling
As crude prices continue to climb, Chinese government price controls on refined oil and other petroleum products are affecting earnings at many Chinese oil and petrochemical producers. Sinochem, PetroChina, Yangzi Petrochemical and Guangzhou Petrochemical have all reported lower operating results for the first quarter, and they expect continued poor performance in the second quarter as well. Sinopec, in fact, expects earnings to decline by 50 percent in the first half of 2008 as compared to the same period in 2007. The government eventually raised price limits in June, but the action was too late to impact the results from the first of the year.

 



 
Indian Companies Looking for International Acquisitions and Activities
With rapid growth in their domestic market, Indian chemical firms are looking for international acquisitions and other activities that will provide access to cheaper feedstocks and new high-growth markets.

Tata Chemicals recently acquired U.S.-based General Chemical Industrial Products for $1.01 billion (Euro 652 million), making it the second largest global Soda ash producer. With the acquisition, the company has established long-term fundamentals based on demand growth prospects, according to vice president R. Mukundan. Tata is also hoping to build a new plant or expand an existing facility in Kenya.

India-based Nirma also purchase a U.S.-based Soda ash producer - Searles Valley Minerals - the only producer of sodium borates, boric acid and sodium sulfate utilizing the more cost-effective method of solution mining.

Reliance Industries has been actively acquiring Polyester producers, including Hualon, now called Recron (Malaysia) and Trevira, located in Germany. The company has also signed a memorandum of agreement with compatriot firm GAIL to develop a gas-based cracker outside of India. The two companies plan to make a proposal to the Qatar government for a $1.3-billion petrochemical plant. Reliance may also invest in a cracker and polyolefins complex in Peru.
 

 



 
Reorganization of Brazilian Chemical Industry
The growing economy in Brazil offers great opportunities for petrochemical companies in the country, including Braskem, Quattor, and state-owned Petrobras, which has stakes in these two companies. Many petrochemical assets in the Northeast have been consolidated into Braskem, while operations in the Southeast have been joined to form Quattor. Braskem hopes to develop a large Ethane-based petrochemical complex in Venezuela that will be competitive with major Middle East ventures. Quattor offers basic petrochemicals, intermediates and plastics, and will account for 40 percent of Brazil's Polyethylene and Polypropylene production capacity once ongoing plant upgrades are completed.

 



 

 
Poor PVC Market Leads PolyOne to Close Plants
PolyOne will close eight Polyvinyl chloride (PVC) plants over the next nine months, reducing its staff by about 150. A decline in the housing and automotive markets combined with rising raw material and energy costs led to the decision to shutdown the facilities. Production will be consolidated in its remaining plants. Six of the sites are located in the United States, and one each in Canada and England.

 



 

 
Experimental Drugs Released from GMP Regs
Experimental drugs in Phase I development will be exempt from some good manufacturing practice (GMP) regulations, according to a final rule published by the FDA. Both small molecule drugs and biologicals will be covered when the rule goes into effect on Sept. 15, 2008. The agency has also issued a guidance document containing recommended approaches for complying with those GMP requirements that still apply to these drugs.

 



 
Pharma Companies Looking to India for R&D - Not Just Manufacturing
India has been a key location for contract manufacturing in the pharma industry for some time. In recent years, though, Indian companies have focused efforts on enhancing their drug discovery and development capabilities, and big pharma is taking notice. Companies like Nicholas Piramal, Dr. Reddy's Laboratories, and Ranbaxy have spun off their discovery divisions off in an attempt to attract such attention. Other firms such as GVK Biosciences, Syngene, Sai Advantium and Accutest are focusing on contract services, such as medicinal chemistry, toxicology and development. Many global pharma companies are also turning to Indian firms for R&D support in the areas of genomics, proteomics, translational research, pathway analysis and other biotech services.

Intellectual property protection remains an issue, as does the inability to retain talented and skilled employees. The government has a new patent plan in place and has committed to the IP rules of the World Trade Organization.
 

 



 
Roche Bids for Genentech; Other Pharma/Bio Deals Announced
Roche Holding hopes to gain full control of Genentech. It has offered $43.7 billion for the outstanding shares in Genentech, of which it already owns 55.9 percent. The deal would be the largest biotech acquisition ever. Many within Genentech and the industry were surprised by the offer. Analysts expect Roche will need to make a higher bid that will more accurately reflect the potential value of Genentech's drug pipeline and its leading cancer therapy Avastin. Although Roche says it will continue to operate Genentech as a separate business, many are concerned that Genentech could lose its identity if it becomes a part of the large pharma firm. A special committee of three independent directors appointed by Genentech has determined that Roche's buyout offer is not covered by any agreement between the companies. Legal action may follow.

Meanwhile, Bristol-Myers Squibb Co. (BMS) has made its own unsolicited offer of $4.5 billion to acquire the remaining 83 percent of shares in ImClone Systems that it does not already own. BMS and ImClone jointly developed the blockbuster cancer treatment Erbitux, and the acquisition would provide access to this key drug's full revenue stream. ImClone also has a robust pipeline of early-stage candidates. ImClone has not responded yet to the bid announcement.

In a deal that has already been reached, Sanofi-Aventis will pay approximately $550 million to purchase vaccine producer Acambis. Sanofi-Pasteur, a Sanofi-Aventis business unit, has worked with Acambis to develop and market a number of different vaccine products. The takeover is a natural step in the relationship between the two companies.
 

 



 
Teva Agrees to Acquire Barr Pharmaceuticals

Teva Pharmaceuticals will purchase Barr Pharmaceuticals for approximately $7.46 billion. With the purchase, Teva gains wider access to emerging markets such as Central and Eastern Europe and expands the company's product portfolio into new areas such as women's medicine.

 



 
U.S. Congress Continues to Pursue Changes at FDA
In response to recent safety issues with imported drugs, toys and animal feeds, members of the U.S. Congress continue to seek changes in how the FDA is managed. Representative John Dingell has introduced a bill on drug imports that would add registration fees and require certification to ensure the purity of ingredients. Senator Charles Grassley wants to make safety evaluators independent of the FDA Office of New Drugs. He believes that the industry has too much influence on approval decisions. Both would like to see a new FDA commissioner that does not come from within the industry.

The two Congressmen, along with other colleagues, have conducted nearly 20 investigations into drug approvals and other issues related to the FDA's performance. Currently, a House panel is trying to determine whether the FDA knowingly approved for sale in the Unites States drugs made by Ranbaxy Laboratories (India) that were manufactured under conditions in violation of cGMP requirements. Allegations have been made that Ranbaxy submitted to the FDA "false and fabricated information." The company strongly denies these charges, and Ranbaxy CEO Malvinder Singh has pointed the finger at an unnamed competitor, saying it has used these allegations as a way to stop the recently announced acquisition of Ranbaxy by Daiichi Pharmaceuticals.
 

 



 

 
Alternative Chemicals Market Shows Huge Potential
The market for non-petrochemical based ingredients will total $46.6 billion (Euro 29.8 billion) in 2008, and will grow 15.3 percent per year to $94.8 billion in 2013, according to BCC Research. Drivers for growth include increasing consumer demand for "greener" products and the need for cheaper feedstocks, more cost efficient production methods and access to novel products and product technologies. Alternative chemicals find use in a number of applications, including cleaning and detergent products, packaging, plastics and other miscellaneous specialty chemical products.

 



 
Another Big U.S. Acquisition: Ashland Agrees to Buy Hercules

Ashland will purchase Hercules for $3.3 billion (Euro 2.12 billion), fulfilling its goal of becoming a leading specialty chemicals company, according to Ashland Chairman and CEO James J. O'Brien. The purchase will strengthen the company's core platform and give Ashland a good position in renewable chemistries. The combined entity would have pro forma revenue above $10 billion. The new company will focus on specialty additives and ingredients, paper and water technologies and specialty resins. The transaction is expected to be completed by the end of 2008.

 



 
Buyer Found for PPG's Auto-Glass Business
Private equity firm Kohlberg & Co. has agreed to purchase the auto-glass and services business of PPG Industries for $330 million (Euro 211 million). PPG will also retain a 40 percent ownership in the new company formed by Kohlberg that will actually make the acquisition. The sale is part of PPG's strategy to focus on coatings and specialty products and reduce its exposure to the automotive market in the United States. A previous $500 million deal with Platinum Equity fell through when the equity firm sued PPG, alleging that PPG misrepresented the financial condition and performance of the company. PPG countersued for a $25 million break-up fee. Litigation is ongoing.

 



 
Difficult Times for Candle Makers
Record prices for paraffin wax and the trend for all things "green" are posing challenges for candle makers. The price for paraffin wax has climbed 40 percent in the past year. Analysts predict that supply and demand will remain unbalanced through 2010. Many candle producers are using substitutes such as vegetable wax or tallow, but formulation challenges remain. Separately, analysts say that as many as 40 percent of candle consumers are looking for green products, and alternative oils like palm and beeswax could help meet this demand. Replacing current packaging with packaging that is comprised of, manufactured, transported and recycled using renewable energy would qualify as green. Fragrances are a challenge, though, because many natural fragrances contain allergens and/or carcinogens, and many popular fragrances cannot be derived from natural materials.

 



 
Government in Singapore Encouraging Investment by Consumer Product Companies
With a highly diverse population and established technology centers, Singapore is an ideal location for consumer product companies to establish research and manufacturing sites for consumer products designed for the Asian market. In the region, demand for consumer products such as perfumes and cosmetics, food and beverages and household care has risen dramatically as incomes have increased. Many international flavor and fragrance and consumer product companies such as Procter & Gamble, Unilever and Johnson & Johnson have already established R&D facilities in Singapore.

 



 
Hexion/Huntsman Saga Continues

Since both Hexion and Huntsman have filed lawsuits against each other regarding their proposed $10.6 billion (Euro 6.7 billion) merger, further communication has taken place. Hexion claims the merger would create an insolvent company, while Huntsman is suing for breach of contract, breach of good faith and fair dealing, defamation, injurious falsehood and commercial disparagement.

Hexion also has stated that Huntsman's estimated second-quarter results support its claims about the untenable financial position of a combined company. Peter Huntsman said he would "fight to the bitter end" to enforce the terms of the merger agreement with Hexion.

Huntsman requested an extension of the merger deadline beyond July 4, 2008, but Hexion said there was no basis to do so. Even so, Huntsman delivered a formal notice of a 90-day extension to the merger agreement. Hexion responded that the extensions violated the terms of the agreement.

Hexion is required to try and save the deal. The company requested additional financing from two lenders already involved in the transaction. The banks rejected the request and questioned whether they should be obligated to proceed at all. Hexion then sent a letter to Huntsman requesting permission to ask for additional financing from other sources. Huntsman received unsolicited offers from several financial investors for additional money to salvage the deal and asked Hexion for permission to share confidential information with the investors. In turn, Hexion referred the unnamed investors to its financial adviser.

The trial of the lawsuit filed by Hexion in the Delaware Court of Chancery is scheduled to begin on Sept. 8, 2008. Huntsman has stated that it expects the lawsuit will be resolved quickly and in its favor, and that the merger between the two companies will take place before mid-September.

In the midst of this turmoil, the European Commission approved the merger on the condition that Hexion divest certain epoxy resin assets in the United States and Germany.
 

 



 
Interest in Solar Energy Drives Growth of Photovoltaics Market
International solar research company Solarbuzz reports that the production of solar energy grew 62 percent annually from 2006 to 2007. This growth rate will likely increase as technology advancements and rising fuel costs, both petroleum and renewable-based, combine to make global markets receptive to solar energy. The demand has producers of silicon wafers, which account for 90 percent of photovoltaic units, scrambling to increase capacity. Leading manufacturers include Hemlock Semicondutor, a joint venture between Dow Corning, Shin-Etsu, Mitsubishi and Wacker Chemie. One of the biggest hurdles for the industry is achieving grid parity with traditional electricity generation methods, which is at least several years away for most regions of the world.

 



 
Penn Specialty Chemicals Finds Buyer in Minakem

Minakem Group has acquired Penn Specialty Chemicals, a producer of Furan-based compounds, for an undisclosed amount. Penn has been renamed PennAkem and will be a subsidiary of Minakem. As part of the Minakem Group, PennAkem is the world leading producer of Furan, Methyltetrahydrofuran and Tetrahydrofufuryl alcohol. With the acquisition, Minakem Group gains access to Penn's production technology, which is based on the use of renewable resources. Other companies in the Minakem Group include Minakem, Chemtec Leuna and Minasolve.

 



 
Pfizer Increases API Outsourcing
As part of its overall strategy to divest additional plants and focus on core activities, Pfizer will increase its outsourcing of manufacturing of both APIs and formulated drug products over the next several years. Since acquiring Pharmacia in 2003, the company has closed or sold 45 of its plants and will reduce the current number of 55 down to 43 by 2010. Within three years, Pfizer expects to outsource 30 percent of its manufacturing business based on cost. Of that 30 percent, 65 percent will be to sites the company has sold. The internal sites that Pfizer retains will still have to compete with external providers. The company will also be reducing the number of contract manufacturers it uses, which presently totals more than 200.

 



 
Phthalates Take Hit from U.S. Congress
The U.S. Congress has drafted a bill to ban the use of some phthalates in children's toys. The sale of toys containing more than 0.1 percent of Di-(2 ethylhexyl) phthalate (DEHP), Dibutyl phthalate (DBP) or Benzyl butyl phthalate (BBP) would be banned permanently, while the sale of toys containing more than 0.1% of Diisononyl phthalate (DINP), Diisodecyl phthalate (DIDP) or Di-n-octyl phthalate (DnOP) would be prohibited on an interim basis until further research can determine their impact on infant health. To become law, the bill must be voted on by both the House and Senate. President George Bush is expected to sign the measure.

Analysts predict that when the ban does become enforced, the Chinese toy industry will be affected significantly. Smaller players will likely be forced out of business or be acquired by larger firms, resulting in consolidation. Most of the larger producers are prepared to meet the requirements because they already must comply with European regulations. The use of phthalates in toys and childcare products has been banned in the European Union since 2005. Because the ban will likely not take effect until January 2009, manufacturers have several months to modify their production processes.
 

 



 
Ranbaxy Acquired by Japanese Pharma Company

Daiichi Sankyo (DS) acquired a 34.8 percent share of Indian firm Ranbaxy Laboratories for approximately $2.4 billion. The Japanese company will gain another 9.4 percent through a preferential allotment and make an open offer to shareholders for an additional 20 percent. Ultimately, Daiichi Sankyo will obtain a 51 percent stake. With the purchase, DS gains access to significant R&D capabilities and an enhanced position in the global generics market. The deal is expected to close in March 2009.

 



 
Unilever Unloads North American Laundry Business
Private equity firm Vestar Capital Partners will buy Unilever's U.S., Canadian and Puerto Rican laundry business for $1.45 billion (Euro 928 million). Unilever is retaining its laundry businesses in Europe, Asia, Africa and Latin America. Unilever is divesting the North American operations because they were a minor player in that market and the region is experiencing slow growth. Vestar will form the company Sun Products Corporation via the merger of the business with its private label brand detergents business, Huish Detergents.

 



 

 
Urea, Ammonia Prices Climbing Dramatically in U.S.
An expected shortage of material has affected the price of Urea traded on the forward market, resulting in a record high of $800/short ton in the United States. With Chinese material being held by the government for domestic use only, the amount of material available for the 2009 planting season is expected to fall short of demand. Prices for Urea are also rising on the international market. Large purchases by Indian companies have driven global Urea prices to record highs, particularly in the Middle East and Central Europe.

Ammonia sellers are hoping to secure contracts above the $700/tonne mark. Prices in the Ukraine have risen to this level, and U.S.-based traders are expecting to see similar gains. Ammonia prices are currently around $585/tonne.
 

 



 

 
International Investment in Green Energy Way Up in 2007: Will Trend Continue?
According to the United Nations, $148 billion in global funding was directed toward the development of renewable energy in 2007, corresponding to a 60 percent increase in such spending in 2006. Most of the investment took place in Europe and the United States, but growing activity was noted in China, India and Brazil. In the United States, $152.2 million was spent on biofuel technology research, with the majority of it spent on discovering routes to Ethanol based on cellulosic materials. During the first four months of 2008, production of biodiesel in the United States increased by 73 percent as compared to the same period a year ago.

Latin American countries together invested over $8 billion in biodiesel and bioethanol projects in 2007. With its fertile lands and ideal climate for growing crops for biofuels production, the region has become a leading player. It looks to serve emerging markets where demand for fuel outpaces petrochemical based oil and gas production. In fact, U.S. biodiesel producers face serious competition from lower-priced material coming from Argentina.

Further activity has continued into 2008. Most recently, India's government agreed to establish a board to oversee biofuel cultivation, production, research and development. The industry in India is pleased to have a government body that will address regulatory issues.

On the negative side, the Environment Committee of the European Parliament recommended that the European Commission reduce the 10 percent biofuels target to 4 percent by 2020 in response to complaints that farmers are switching from food crops to fuel crops, leading to higher food prices. Alternative measures, such as producing renewable fuels from nonfood sources and increasing the use of biogas, hydrogen or electricity for vehicles were also suggested.

Leading French biodiesel firm Sofiproteol has indicated that, in light of the recommendation for lower biofuels requirements, the company will review its long-term investments, including the development of second-generation cellulosic-based biofuel plants. In a letter to the heads of the G8 nations, the major associations of renewable fuelspredicted that increased investment in biofuels production would lead to lower prices for oil and alleviate the global food crisis. The letter also stated that gasoline prices would be much higher without biofuel products in the market, and that higher food prices could be attributed mainly to higher fuel costs for farmers.
 

 



 
Japanese Firm Acquires Parent Company of American Peptide

Otsuka Chemical Company will acquire Ito Life Sciences, the parent company of American Peptide Company. Details of the transaction were not disclosed. American Peptide produces both research and GMP-grade peptides and peptide conjugates, while Otsuka manufactures both fine and industrial chemicals and has a presence in most regions around the world. Access to broader markets and additional financial resources will benefit the company, according to American Peptide president and COO Takahiro Ogata.

 



 

 
Benzene, Styrene, Toluene Hit Record Prices in Europe
European Benzene spot prices have risen to a new record of $1,430 to $1450/tonne. These prices recently grew nearly $100/tonne in a day. Several production problems, which have resulted in reduced supplies, combined with higher crude values, have been the major drivers of the price hikes. Contract prices for August have settled a bit lower at $1,330 to $1,380/tonne, as many buyers held back to see what the market would do.

Market tightness and higher Benzene feedstock costs have driven European spot Styrene to a new record high of $1,830/tonne. Many producers have cut capacity in response to cost concerns and are buying on the spot market to fulfill contracts, resulting in the reduced availability of material. With prices so high, it is anticipated that some buyers will purchase Styrene from producers in the United States.

Toluene contracts also settled at a new record high, between $1,220 and $1,230/tonne. The higher prices are driven largely by hikes in crude oil. Spot Toluene prices have also hit record highs. Higher Toluene and other downstream prices have reduced demand, resulting in a slightly lower July contract price for Benzene. Considering market fundamentals, the decrease was deemed necessary, but producers cannot be expected to go lower as their margins would be too diminished.
 

 



 
Caustic Soda Prices Continue to Climb
Even with production capacities above 90 percent, U.S.-based Caustic soda producers are having a hard time meeting demand. Demand for Chlorine, which is produced along with Caustic soda, usually drives production rates, but currently the high profit margins associated with Caustic soda are driving production decisions. Production rates had dropped significantly due to the slowdown in the U.S. housing market. But high spot prices in overseas markets led manufacturers to boost capacity to meet the growing international demand. Export prices for Caustic soda have climbed to as high as $860/dry tonne.

Prices for Caustic soda have also risen dramatically in the domestic market, and some buyers in the United States could be pushed out. Producers had nominated a 32 percent price increase for July contracts. Caustic soda is used to produce basic commodities such as bleach, Aluminum and paper. These industries could be forced to lower operating rates or find alternative production routes if Caustic soda prices surpass the $1,000/dry short ton market, which some expect.
 

 



 
European Phenol Chain Struggling
European producers of Acetone, Phenol, Adipic acid, Caprolactam, Nylon and Methyl methacrylate are faced with a slowdown in demand in many downstream markets. The slowdown in the economy in the United States has impacted many of these sectors around the world. In China, reduced export tax rates and new labor laws, plus restrictions on the production and shipment of chemicals because of the Olympic Games are also having a negative effect. At the same time, the rising raw material and energy prices are placing pressures on margins because producers cannot pass on these additional costs. The difficult market conditions are anticipated to last through the end of the year, at least.

 



 
Global Acetone Prices Continue to Rise
Spot prices for Acetone in the United States, Europe, Asia, India and the Middle East are mounting in response to tight global supplies and rising Propylene feedstock costs. In the United States, the July truck price for Acetone, which is sold to the solvent and distributor markets, increased by 30 percent. Dow Chemical declared "excused performance" to its distribution partners to avoid selling Acetone at a loss, and indicated that the company would be allocating production and deliveries among its customers. Many producers in the country have reduced operating rates in response to high Propylene and natural gas costs.

In Europe, spot prices remained flat for the past six months as new capacity came onstream. Capacity was reduced recently as a result of strikes and a lack of export opportunities, resulting in shorter supply. Rising Propylene feedstock costs are also driving up the price of both contract and spot material. Despite tightness in the market, several producers have plant turnarounds scheduled during the next few months.

Asian Acetone producers raised prices as well, reacting to higher raw material costs. Indian and Middle Eastern Acetone prices climbed in response to the higher prices in other parts of the world.
 

 



 

 
Cognis Makes Further Divestments, Focus Is on Wellness/Sustainability Markets

Cognis announced that it will sell its 50 percent stake in Cognis Oleochemicals to partner PTT Chemical for $165 million (Euro 104 million). PTT and its partner Sime Darby Plantation will continue to supply Cognis with oleochemical basestock. Cognis has also agreed to sell its Pulcra Chemicals subsidiary to Fashion Chemicals for $42 million (Euro 26.3 million). Pulcra manufactures chemicals for the fiber, textile and leather industries. Cognis' strategy is to focus on core businesses that target wellness and sustainability.

 



 

 
Butadiene Prices Hit New High in Asia
Despite lower crude values, Asian Butadiene sold on the spot market continues to experience dramatic price hikes as tightness continues. Prices climbed over 6.5 percent in the last week, and more than 13 percent in the last month. Industry players expect the tightness to continue and prices to remain high for the foreseeable future.

 



 

 
U. S. Paint and Coatings Industry Pleased with Recent Court Decision
Paint and coating manufacturers in the United States were happy to hear the recent ruling by the Supreme Court of Rhode Island, which overturned a lower state court decision holding paint companies liable for the removal/remediation of lead-based paint in buildings where children could be exposed.

The state argued that paint producers should be held liable for the removal of lead-based paints and for any healthcare costs associated with exposure to lead-based paint. The case was a "public nuisance" claim, and many considered it be simply an attempt to generate billions of revenue at the expense of the paint and coatings industry.

The high court essentially agreed. Because lead-based paints were legal and nondefective products when they were sold prior to the 1978 ban, and were safe if maintained, the court ruled that the industry is not liable for removal costs or health-related costs. The state is responsible for resolving the issue.

Other public nuisance cases have also been overturned in Missouri, New Jersey and Illinois. The Rhode Island ruling, however, was the most definitive, and will likely dissuade other states from filing similar suits against lead pigment producers. According to analysts, it could also affect the outcome of other pending cases.
 

 



 

 
Petchem Producers Find Vietnam Attractive
Foreign companies find Vietnam's 8 percent/year growth a great incentive for investment in the country, and petchem producers are no exception. Demand for polymers is very strong and growing rapidly, with leading polymers including Polyethylene, Polypropylene, Styrenics, Polystyrene, expandable Polystyrene, Acrylonitrile-butadiene styrene and Polyvinyl chloride. Major producers including Mitsui, Idemitsu Kosan, Vietnam Oil and Gas (Petrovietnam) and Vietnam Chemical (Vinachem) have already made or are now making investments in the country.

Long Son Petrochemical Co. just received approval from the Vietnamese government to build a $3.77 billion (Euro 2.4 billion) complex in the south that should be operational in 2013. Sinopec and Petrolimex are considering construction of a $4.5 billion refinery and chemical plant in the central part of the country. If all projects come onstream, Vietnam will become a leading polymer producer in the Association of South East Asian Nations (ASEAN) region. It will face competition from countries such as Singapore, Thailand and Malyasia, however.
 

 



 

 
Bayer Schering Pharma Appoints New CEO

Andreas Fibig, previously a senior vice president at Pfizer, has been appointed by Bayer as CEO of Bayer Schering Pharma. Fibig replaced Arthur Higgins, who will remain as chairman and CEO of the Bayer Healthcare business. Fibig has held positions at Schering AG (acquired by Bayer in 2006), Boehringer Ingelheim and Pharmacia.

 



 
New CEO for Sunoco
Lynn Elsenhans, who recently joined Sunoco, has been elected CEO and president effective Aug. 8, 2008, and will replace the retiring John Drosdick. Elsenhans came to Sunoco from Shell, where she served as executive vice president of global manufacturing.

 



 

 
Carbon Credits and Emissions Trading Could Have Significant Impact on Chemical Industry
With a global agreement to reduce carbon emission by 50 percent by 2050 adopted by many countries, the $14 billion carbon credit market is set to expand rapidly. Carbon emission reduction trading platforms are already in place in Asia and Europe, with further exchanges in Asia under discussion.

The United States continues to resist ratification of the Kyoto Protocol. Most recently, the Bush administration said it would not regulate the emission of greenhouse gases (GHGs) under the Clean Air Act (CAA), defying a Supreme Court order in doing so. Instead, the EPA issued a notice of proposed rulemaking, asking for public comment on "the effects of climate change and the potential ramifications of the Clean Air Act in relation to greenhouse-gas emissions." Many in the industry and at the EPA believe that the CAA is not the appropriate forum for regulating GHGs, and that Congress should establish a national policy to manage this issue.

Separately, the European Commission has proposed changes to the European Union's Emission Trading Scheme (ETS) to enable reduction of greenhouse-gas emissions by 20 percent by 2020. The proposals specifically cover the petrochemical and inorganic subsectors, and the proposals reduce and ultimately eliminate free allowances to chemical companies, reduce emissions caps annual, and include provisions that prevent or at least make costly the use of "off-shoring" as a means for avoiding participation in the ETS.

Many believe the changes could have profound effects on the petrochemical industry, adding a significant financial burden that would be difficult to pass on to customers, considering the highly competitive global marketplace. Both the European Parliament and the European Council have shown an interest in getting these proposals adopted by spring 2009.
 

 



 
Impact of Olympics On Chinese Chems Beginning
The Chinese government has issued tighter regulations on several chemicals including Ethylene, Phenol, Nitric acid, Sulfur and Perchloric acid that will be in effect until Sept. 30, 2008. Companies without safety licenses or business certificates will not be allowed to buy or sell these chemicals, and purchasers must provide identity cards. Many "heavy pollution enterprises," including metal and petrochemical manufacturers in and near Beijing, have already shut down operations and are expected to remain closed for several weeks after the Olympic Games are over. New harbor regulations in Olympic co-host cities across the country include restrictions on transportation of chemicals. Products considered hazardous goods or explosives will not be allowed to enter or pass through Beijing and several other cities from July 11through Aug. 31, 2008. Traders expect these restrictions to impact the shipment of chemicals in the country significantly.

 



 
Scientists Claim NF3 Poses Greater Greenhouse Risk than CO2
Nitrogen trifluoride (NF3), used as a plasma etchant and for equipment cleaning in the semiconductor industry, has a lifetime of 550 years and a global warming potential thousands of times greater than Carbon dioxide, according to scientists in the Earth System Science Department at the University of California, Irvine. The substance is not included in the Kyoto Protocol on Climate Change because it was produced in much smaller quantities in 1995 when the Protocol's data was gathered. Leading producers of NF3 include Air Products, Formosa Plastics, Mitsui Chemicals and Kanto Denka Kyogo. According to scientists, current production is approximately 4,000 metric tonnes/year. Planned expansions could double that by 2010. While most of the NF3 used in production processes is destroyed, scientists argue that some fraction must escape to the atmosphere during the process and when the substance is being transported or disposed.

Air Products, a major producer of Nitrogen trifluoride, responded that the study presents an "inaccurate and implausible scenario." According to Corning Painter, vice president of global electronics for the company, NF3 serves as a source for Fluorine, which is used to clean manufacturing equipment. Of the two percent that isn't consumed in the process, most of the gas is destroyed by emission control equipment.
 

 



 

 
Famous Quotes of the Month

"If A is success in life, then A equals X plus Y plus Z. Work is X; Y is play; and Z is keeping your mouth shut." (Albert Einstein)

"A company is an organic, living, breathing thing, not just an income sheet and balance sheet. You have to lead it with that in mind." (Carleton S. Fiorina)

"The difficulty lies, not in the new ideas, but in escaping the old ones, which ramify, for those brought up as most of us have been, into every corner of our minds." (John Maynard Keynes)

 

 



 

 
Why do people start walking in a synchronized manner when they walk side-by-side?
There could be various reasons for this occurrence. First of all, we learn to conform to those around us as we grow older. We don't want to look like we're going against the flow as an adult in a social environment. Also, it's simply easier to talk with someone if you are walking a similar pace. Finally, think about hip movement. Unless you want to bump hips with your walking companion, it's probably a good idea to make sure your natural sway does not "sass-shay," as it were, and wind up in the way.

 



 

 
In This Issue

 
Featured Article
 
Business/Finance
 
Companies
 
Pharma
 
Fine & Specialty Chemicals
 
Agrochemicals
 
Biotech
 
Commodity Chemicals
 
Fats and Oils
 
Intermediates
 
Paints & Coatings
 
Plastics
 
Personnel
 
General
 
Famous Quotes
 
Imponderables
 

 






 

 

Corporate HQ:
9101 LBJ Frwy., Suite 310
Dallas, TX 75243 USA
Tel: (214) 349-6200
Fax: (214) 349-6286

Unsubscribe or update your email address.
Email Marketing
9101 LBJ Frwy., Suite 310 | Dallas, TX 75243